Peptide Nasal Sprays: How They Work and Which Peptides Are Available

1. Why some peptides work intranasally

Most peptides are destroyed in the stomach, which is why they are usually injected. The nose offers a third option. The nasal cavity is lined with a thin, highly vascular mucous membrane sitting just millimeters from both the bloodstream and the olfactory nerves. A peptide sprayed onto that surface can take two routes at once: it can absorb into systemic circulation, and a portion can move along the olfactory and trigeminal nerve pathways toward the central nervous system.

The catch is that not every peptide is a good nasal candidate. The nose absorbs small, lipophilic molecules far more readily than large, water-loving ones. Short neuropeptides like Semax (7 amino acids) and Selank (also short) are good fits because they are small and their target is the brain. Large peptides and proteins absorb poorly through nasal tissue and are better delivered by injection. So the nasal sprays you actually see compounded are a self-selected group: small, neuroactive, and aimed at the brain or at fast on-demand effects.

One honest framing up front: the nasal route is a delivery convenience and a plausible nose-to-brain shortcut, not a magic upgrade. According to PubMed, a 2018 review of nose-to-brain delivery noted that despite decades of promising preclinical work, very few intranasal central-nervous-system drugs have reached market approval, largely because human clinical evidence for meaningful brain delivery remains limited (DOI).

2. The blood-brain barrier and the nasal-to-brain pathway

The blood-brain barrier is a tight layer of endothelial cells that keeps most large molecules in the blood from entering brain tissue. For brain-targeted peptides, this barrier is the central problem: even a peptide that reaches the bloodstream may never cross into the brain in useful amounts. The appeal of the nasal route is that it offers a partial way around the barrier.

1. Olfactory pathway. At the roof of the nasal cavity, olfactory sensory neurons project directly to the olfactory bulb in the brain. Molecules deposited high in the nose can, in animal models, travel along and around these neurons into the central nervous system without passing through the bloodstream.
2. Trigeminal pathway. Branches of the trigeminal nerve also innervate the nasal mucosa and connect to the brainstem, providing a second nerve-associated route inward.
3. Systemic pathway. The rest of the absorbed dose enters the blood through the nasal mucosa and then has to cross the blood-brain barrier the conventional way, the same as an injected dose.

The important caveat: most direct nose-to-brain evidence comes from rodents, where the anatomy is more favorable and the doses are large relative to body size. In humans, how much peptide actually reaches brain tissue by the olfactory route is still debated and probably small. The nasal route is best understood as raising the odds of brain exposure, not guaranteeing it.

3. Semax: nootropic and neuroprotective

Semax is a synthetic 7-amino-acid peptide derived from a fragment of ACTH (the ACTH 4-10 sequence) with the hormonal activity stripped out. It was developed in Russia, where intranasal Semax is used clinically for stroke recovery, cognitive complaints, and optic-nerve conditions. Outside Russia it is not approved and is available only as a compounded nasal spray.

Mechanism: Semax modulates brain-derived neurotrophic factor (BDNF) and the catecholamine systems involved in focus and learning. According to PubMed, a rat study found that a single intranasal application of Semax increased hippocampal BDNF protein and its trkB receptor signaling and improved a learned avoidance task, which the authors proposed as the basis for its cognitive effects (DOI).

Evidence honesty: The mechanistic and animal data are genuinely interesting, and there is a body of Russian clinical literature on stroke and attention. But there are no large, replicated, Western randomized controlled trials, and Semax is not FDA-approved. Treat the cognitive claims as plausible and mechanistically grounded but not proven to the standard of an approved drug.

Typical compounded form: RxPepsDirect offers Semax paired with Selank as a single nasal spray (Semax/Selank Nasal Spray, $150/spray bottle), dosed at roughly 250 micrograms per spray, one spray in each nostril daily. The combination is a 30-day beyond-use-date product because nasal-spray formulations have shorter stability than lyophilized injectables.

→ Full protocol: Semax/Selank guide

4. Selank: anxiolytic without sedation

Selank is a synthetic analog of tuftsin, a naturally occurring immune-active peptide. Like Semax it was developed in Russia, where it is used as an anti-anxiety agent. The selling point is anxiolysis without the sedation, dependence, or cognitive dulling associated with benzodiazepines.

Mechanism: Selank appears to modulate GABA and serotonin signaling and to influence expression of enkephalin-degrading enzymes, producing a calming effect. According to PubMed, a rat study under chronic mild stress found that Selank reduced anxiety measures and that its anxiolytic activity was comparable to the benzodiazepine diazepam, suggesting overlapping mechanisms (DOI).

Evidence honesty: The same caveat applies as for Semax. The human data are largely Russian, small, and not replicated in large Western trials, and Selank is not FDA-approved. The mechanism is plausible and the side-effect profile in available reports is mild, but this is an investigational-grade peptide, not a first-line anxiety treatment.

Contraindications and flags: Providers flag Selank for review in patients on lithium or other psychiatric medications, and avoid it in active psychosis. It is not a substitute for evaluation and treatment of a diagnosed anxiety disorder.

→ Full protocol: Selank guide

5. PT-141: sexual response (also injectable)

PT-141 (bremelanotide) is the nasal peptide with the strongest formal clinical pedigree, and also the clearest cautionary tale about the nasal route. It is a melanocortin-4 receptor agonist that acts in the brain on the neural pathways of sexual desire, rather than on blood flow the way PDE5 inhibitors like sildenafil do.

The nasal history matters here. According to PubMed, PT-141 was originally developed by Palatin specifically as a nasal spray for erectile dysfunction and female sexual dysfunction, advancing through phase 2 trials (PubMed 15134289). That nasal program was later discontinued after the intranasal route produced transient increases in blood pressure. The molecule was reformulated as a subcutaneous injection, and that injectable version (Vyleesi) is what the FDA approved for premenopausal women with hypoactive sexual desire disorder. According to PubMed, the pivotal phase 3 RECONNECT studies that supported approval used subcutaneous bremelanotide 1.75 mg, not a nasal spray (DOI).

What this means practically: A 503A pharmacy can still compound PT-141 as a nasal spray, and RxPepsDirect offers both an injectable PT-141 vial ($75/10mg) and a PT-141 Nasal Spray ($99), used about 45 minutes before activity. But the nasal version is off-label compounding, and it carries exactly the blood-pressure caution that ended the original nasal development. Providers flag PT-141 for uncontrolled hypertension and cardiovascular disease and screen for PDE5-inhibitor use. If you want the route with FDA-grade efficacy and safety evidence, that is the subcutaneous form, not the spray.

→ Full protocol: PT-141 guide

6. Oxytocin: bonding, mood, and social cognition

Oxytocin is the peptide hormone behind bonding, trust, and social connection, and intranasal oxytocin is the single most-studied nose-to-brain peptide in humans. That large body of research is also a useful reality check on the whole category.

What the research shows: Early small studies suggested intranasal oxytocin could enhance trust, empathy, and social cognition, which drove enormous interest in it as a treatment for autism and social anxiety. But the larger, better-controlled trials have been sobering. According to PubMed, a 24-week phase 2 randomized controlled trial published in the New England Journal of Medicine in children and adolescents with autism spectrum disorder found that intranasal oxytocin produced no significant benefit over placebo on the primary social- withdrawal outcome (DOI).

Evidence honesty: Intranasal oxytocin is a textbook case of early enthusiasm outrunning the data. The bonding and mood effects some people report are real to them, and oxytocin is widely used off-label for intimacy and connection, but the high-quality trial evidence for durable clinical benefit is weak to negative. Use it with modest expectations.

Forms and a safety note: Through RxPepsDirect, oxytocin is most commonly prescribed as a sublingual troche (50 IU and 120 IU, $4.00/troche) rather than a spray, but it can be compounded intranasally. Optimal Balance Pharmacy compounds and fills whichever form the provider prescribes. Oxytocin is an automatic denial in pregnancy outside of a labor context, because it stimulates uterine contractions.

→ Full detail: Oxytocin guide

7. DSIP: sleep

DSIP (Delta Sleep Inducing Peptide) is a naturally occurring neuropeptide named for its association with delta-wave (deep) sleep. It is included here because it is frequently discussed alongside intranasal nootropics, but it is worth being blunt about both its delivery and its evidence.

Evidence honesty: Despite a name that promises a lot, the human data for DSIP are old, small, and inconsistent. According to PubMed, a review in the European Journal of Anaesthesiology summarized DSIP as a peptide with a wide range of proposed effects on sleep and stress but without robust, reproducible clinical confirmation (DOI). It is not FDA-approved and should be considered investigational.

Form note: Through RxPepsDirect, DSIP is prescribed as an injectable vial ($80/10mg), not as a nasal spray, and Optimal Balance Pharmacy compounds and fills it. If you are reading this page hoping for a nasal sleep peptide, the honest answer is that DSIP is usually injected and its sleep benefit is not well established.

→ Full detail: DSIP guide

8. Bioavailability: nasal vs injection

Bioavailability is the fraction of a dose that reaches the bloodstream in active form. A subcutaneous injection of a peptide typically delivers most of the dose into circulation. A nasal spray usually delivers far less, often in the low-single-digit-percent range for peptides, because the molecule has to survive enzymes in the mucosa, resist being swept away by mucociliary clearance, and cross the nasal lining before it drips out or is swallowed.

The practical takeaway: choose the nasal route when the target is the brain and convenience matters, and accept that you are trading away dose certainty. Choose injection when reliable systemic levels matter more than avoiding a needle.

9. Dosing precision challenges

The biggest weakness of nasal peptides is not safety, it is consistency. Several things conspire to make the delivered dose vary from one use to the next:

• Drip-out and swallowing. Some of the spray runs down or is swallowed before it absorbs, and the swallowed fraction is largely destroyed in the gut.
• Mucociliary clearance. The nose continuously sweeps material toward the throat, shortening the contact time the peptide has to absorb.
• Congestion and inflammation. A cold, allergies, or a deviated septum can dramatically change how much peptide lands on absorptive tissue.
• Technique. Spray angle, depth, and whether you sniff hard all change deposition. Aiming up and slightly out toward the olfactory region, and avoiding a forceful sniff that sends spray down the throat, improves consistency.

Nasal sprays are dosed in actuations (sprays), where each metered pump delivers a fixed volume containing a set amount of peptide. The Semax/Selank spray, for example, is built to deliver roughly 250 micrograms per spray. That metering helps, but it cannot fully correct for the absorption variability above, which is why providers tend to assess response over weeks rather than chasing exact blood levels.

10. Storage and shelf life

Nasal-spray peptides generally have shorter shelf lives than lyophilized injectables because the peptide sits dissolved in aqueous solution, where it degrades faster than a freeze-dried powder. The Semax/Selank and PT-141 nasal sprays compounded for RxPepsDirect patients carry a 30-day beyond-use-date, versus the 90 to 180 day beyond-use-dates common for compounded injectable vials.

Practical handling rules: keep the spray refrigerated unless the pharmacy label says otherwise, keep it upright, do not freeze it, and discard it at the printed beyond-use-date even if liquid remains, because potency and sterility are no longer assured past that point. Because nasal peptides are dispensed pre-mixed and ready-to-use, there is no reconstitution step on your end.

11. Side effects unique to nasal administration

Beyond each peptide's own systemic effects, the nasal route adds a layer of local side effects that injections do not have:

• Nasal irritation and burning. A transient stinging or burning sensation on application is common, especially early on.
• Congestion and runny nose. The mucosa can react to repeated spraying with congestion or rhinorrhea.
• Altered taste or smell. Drip-down to the back of the throat can leave a temporary taste, and some users report brief changes in smell.
• Throat irritation. The swallowed fraction can irritate the throat.

Then there are the peptide-specific systemic effects that have nothing to do with the route and everything to do with the molecule: PT-141 can raise blood pressure and cause nausea and flushing; oxytocin must be avoided in pregnancy outside of labor; Semax and Selank are flagged in patients on lithium or psychiatric medications. None of these peptides are FDA-approved as nasal sprays, which is exactly why a provider screen for contraindications is not optional.

12. How to get a nasal peptide prescription

Every nasal peptide on this page is a compounded medication, which means it requires a prescription and a licensed compounding pharmacy. The path is the same as for any RxPepsDirect peptide:

1. Online intake. Complete a structured health history covering current medications (psychiatric drugs and lithium for Semax/Selank, cardiovascular history for PT-141), pregnancy status for oxytocin, and your goals. No in-person visit is required.
2. Provider review. A licensed RxPepsDirect provider reviews your intake, applies the relevant contraindication flags, and decides whether a nasal formulation fits your goal or whether an injectable or sublingual form is the better choice.
3. Prescription and fill. The provider writes the prescription and sends it to Optimal Balance Pharmacy, a licensed 503A compounding pharmacy. Optimal Balance compounds, fills, and ships the nasal spray pre-mixed and ready to use. The pharmacy collects the medication payment directly.
4. Follow-up. Because nasal dosing is assessed by response rather than precise blood levels, the provider checks in on how you are tolerating and responding before continuing or adjusting.

Two parties, two charges. RxPepsDirect bills a flat $39 medical visit fee for the prescriber review. The medication itself is billed separately by Optimal Balance Pharmacy at its compounded price (for example, $150 for a Semax/Selank spray bottle or $99 for a PT-141 nasal spray). RxPepsDirect writes the prescription; it does not dispense, ship, or sell the medication.

Where this is available: RxPepsDirect prescribers are licensed in 28 U.S. States. Eligibility is confirmed during intake based on the state where you are located.